Company Filing History:
Years Active: 1978
Title: Innovations of Ichiro Yamawaki
Introduction: Ichiro Yamawaki, based in Tokushima, Japan, is a notable inventor known for his contributions in the field of pharmaceuticals. With a specific focus on 5-fluoropyrimidin-4-one derivatives, his innovations aim to advance anti-tumor therapies.
Latest Patents: Ichiro Yamawaki holds two significant patents that showcase his expertise. The first patent is for the "Preparation of 5-fluoropyrimidin-4-one derivatives". This invention describes a 5-fluoropyrimidin-4-one derivative represented by a complex formula where R can be straight-chain or branched-chain alkyl having 4 to 18 carbon atoms, straight-chain or branched-chain alkenyl having 2 to 18 carbon atoms, alkylene oxido having 3 to 10 carbon atoms, or aryl or aralkyl. The second patent focuses on "5-Fluoropyrimidin-4-one compositions," which includes not only the derivative itself but also processes for preparing the derivative and a formulation for an anti-tumor composition. This composition comprises the derivative as an effective component and an excipient, indicating a well-thought-out approach towards therapeutic applications.
Career Highlights: Ichiro Yamawaki is currently associated with Taisho Pharmaceutical Co., Ltd., where he continues to develop his insights into pharmaceutical chemistry. His work has contributed to the advancement of treatment options in the medical sector, particularly related to cancer therapies.
Collaborations: In his professional journey, Ichiro has collaborated with esteemed colleagues, including Mitugi Yasumoto and Junichi Yamashita. Their combined expertise has likely fostered a productive environment for innovation and development in their projects.
Conclusion: Ichiro Yamawaki's innovative work in the field of pharmaceuticals, particularly with 5-fluoropyrimidin-4-one derivatives, underscores his commitment to addressing significant health challenges. His patents reflect a deep understanding of chemical applications in medicine, positioning him as a valuable contributor to cancer research and treatment solutions.